Exact Mass: 744.2781774
Exact Mass Matches: 744.2781774
Found 88 metabolites which its exact mass value is equals to given mass value 744.2781774
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
(+)-lyoniresinol 2a-O-alpha-D-galactopyranosyl-3a-O-beta-D-glucopyranoside
(3R,4R)-2-hydroxy-3,4-bis(3,5-dimethoxy-4-beta-D-glucopyranosiloxybenzyl)tetrahydrofuran
(+)-lyoniresinol 9-O-beta-D-glucopyranosyl-(1<*>4)-beta-D-glucopyranoside|(+)-lyoniresinol 9-O-beta-D-glucopyranosyl-(1[*]4)-beta-D-glucopyranoside
(+)-lyoniresinol 4,4-bis-O-beta-D-glucopyranoside|(-)-Lyoniresinol-4,4-bis-O-??-D-glucopyranoside
(+)-lyoniresinol 9-O-beta-D-glucopyranosyl-(1?3)-beta-D-glucopyranoside|pteleifoside G
(3S,5R,6S,7E,9R)-7-megastigmene-3,6,9-triol 3-O-beta-D-[2-O-beta-D-(6-O-sinapoyl)apiofuranosyl]glucopyranoside|tenuiside F
(-)-(8R,7E)-4-hydroxy-3,3,5,5-tetramethoxy-8,4-oxyneolign-7-ene-9,9-diol 4,9-bis-O-beta-D-glucopyranoside
(+)-lyoniresinol 3a-O-alpha-D-galactopyranosyl-(1->6)-beta-D-glucopyranoside
(7S*,8R*,7S*,8R*)-huazhongilexin 9-O-(2-feruloyl)-beta-D-xylopyranoside
[3-hydroxy-3-[(4-hydroxyphenyl)methyl]-4-oxo-4-[[4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]methoxy]butan-2-yl] 3-acetyloxy-2-hydroxy-2-[(4-hydroxyphenyl)methyl]butanoate
6-methylheptyl 2-[methyl-bis[[2-(6-methylheptoxy)-2-oxoethyl]sulfanyl]stannyl]sulfanylacetate
C31H60O6S3Sn (744.2573809999999)
Orvepitant maleate
C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent Orvepitant maleate (GW823296 maleate) is potent, selective, orally active and well-tolerated neurokinin-1 receptor (NK-1) antagonist with a pKi of 10.2 for human neurokinin-1 receptor. Orvepitant maleate can across the blood-brain barrier. Orvepitant maleate has the potential for depressive disorder and chronic refractory cough (CRC) treatment[1][2].
(+)-lyoniresinol 4,4-bis-O-beta-D-glucopyranoside
A lignan that consists of (+)-lyoniresinol attached to two beta-D-glucopyranosyl units at positions 4 and 4 via glycosidic linkages. Isolated from Indigofera heterantha, it exhibits inhibitory activity against lipoxygenase.
[3-Hydroxy-3-[(4-hydroxyphenyl)methyl]-4-oxo-4-[[4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]methoxy]butan-2-yl] 3-acetyloxy-2-hydroxy-2-[(4-hydroxyphenyl)methyl]butanoate
8-ethyl-1,6,7,8,11-pentahydroxy-10-{[5-({4-hydroxy-5-[(5-hydroxy-6-methyloxan-2-yl)oxy]-6-methyloxan-2-yl}oxy)-6-methyloxan-2-yl]oxy}-9,10-dihydro-7h-tetracene-5,12-dione
8-[(1r,5s,6r)-6-[2,4-dihydroxy-3-(3-methylbut-2-en-1-yl)benzoyl]-5-(4-hydroxyphenyl)-3-methylcyclohex-2-en-1-yl]-2-(2,4-dihydroxyphenyl)-5,7-dihydroxy-3-(3-methylbut-2-en-1-yl)chromen-4-one
8-ethyl-1,6,8,11-tetrahydroxy-10-{[4-hydroxy-5-({4-hydroxy-5-[(5-hydroxy-6-methyloxan-2-yl)oxy]-6-methyloxan-2-yl}oxy)-6-methyloxan-2-yl]oxy}-9,10-dihydro-7h-tetracene-5,12-dione
2-[(4,5-dihydroxy-6-{[7-hydroxy-1-(4-hydroxy-3,5-dimethoxyphenyl)-3-(hydroxymethyl)-6,8-dimethoxy-1,2,3,4-tetrahydronaphthalen-2-yl]methoxy}-2-(hydroxymethyl)oxan-3-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
(7r,8r,10s)-8-ethyl-1,6,7,8,11-pentahydroxy-10-{[(2r,5s,6s)-5-{[(2s,4s,5s,6s)-4-hydroxy-5-{[(2s,5s,6s)-5-hydroxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-9,10-dihydro-7h-tetracene-5,12-dione
(8r)-8-ethyl-1,6,7,8,11-pentahydroxy-10-{[5-({4-hydroxy-6-methyl-5-[(6-methyl-5-oxooxan-2-yl)oxy]oxan-2-yl}oxy)-6-methyloxan-2-yl]oxy}-7,9,10,11a-tetrahydro-5ah-tetracene-5,12-dione
1-acetyltrichilin h
{"Ingredient_id": "HBIN002260","Ingredient_name": "1-acetyltrichilin h","Alias": "NA","Ingredient_formula": "C38H48O15","Ingredient_Smile": "NA","Ingredient_weight": "744.788","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9238","PubChem_id": "NA","DrugBank_id": "NA"}
2-acetyl-29-deacetyl-29-isobutyrylsendanin
{"Ingredient_id": "HBIN005122","Ingredient_name": "2-acetyl-29-deacetyl-29-isobutyrylsendanin","Alias": "NA","Ingredient_formula": "C38H48O15","Ingredient_Smile": "NA","Ingredient_weight": "744.788","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8719","PubChem_id": "NA","DrugBank_id": "NA"}
[(1r,2r,7r,10s,14r,15r,16s,17r,18s,19s,20r)-18,19,20-tris(acetyloxy)-6-(furan-3-yl)-16-(2-methoxy-2-oxoethyl)-7,12,17-trimethyl-4-oxo-5,11,13,21-tetraoxaheptacyclo[10.8.1.1¹⁴,¹⁷.0¹,¹⁰.0²,⁷.0¹⁰,¹⁵.0¹⁴,¹⁹]docosan-15-yl]methyl acetate
2-{[8-(4-hydroxy-3,5-dimethoxyphenyl)-6-(hydroxymethyl)-1,3-dimethoxy-7-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-5,6,7,8-tetrahydronaphthalen-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
methyl (2s)-2-(acetyloxy)-2-[(1r,2r,6s,7s,8s,10s,12s,14s,15r,16s,17r,18r,19r,20r)-8,18,20-tris(acetyloxy)-6-(furan-3-yl)-7,12,15,17-tetramethyl-4-oxo-5,11,13,21-tetraoxaheptacyclo[10.8.1.1¹⁴,¹⁷.0¹,¹⁰.0²,⁷.0¹⁰,¹⁵.0¹⁴,¹⁹]docosan-16-yl]acetate
(1r,3r,4r,7r,8s,10s,11r,14r)-3,10-dihydroxy-6-[(2e)-1-hydroxy-3-[(1r,2s,3s,4s,5s)-5-hydroxy-8-[(2e,4e)-1-hydroxyhexa-2,4-dien-1-ylidene]-1,3,5-trimethyl-6,7-dioxobicyclo[2.2.2]octan-2-yl]prop-2-en-1-ylidene]-13-[(2e,4e)-1-hydroxyhexa-2,4-dien-1-ylidene]-1,4,8,11-tetramethyl-2,9-dioxapentacyclo[8.4.0.0³,⁸.0⁴,¹⁴.0⁷,¹¹]tetradecane-5,12-dione
methyl (2s)-2-(acetyloxy)-2-[(1r,2r,6s,7s,8s,10s,12s,14s,15r,16s,17r,18r,19s,20r)-8,18,20-tris(acetyloxy)-6-(furan-3-yl)-7,12,15,17-tetramethyl-4-oxo-5,11,13,21-tetraoxaheptacyclo[10.8.1.1¹⁴,¹⁷.0¹,¹⁰.0²,⁷.0¹⁰,¹⁵.0¹⁴,¹⁹]docosan-16-yl]acetate
(3-{2-[(1r,2r,3s)-3-{2-[(5as,6r,7r,9as)-6-hydroxy-2,2,5a,7-tetramethyl-hexahydro-3h-1-benzoxepin-6-yl]ethyl}-1,3-dimethyl-2-(3-oxobutyl)cyclohexyl]-2-oxoethyl}-4-(sulfooxy)phenyl)oxidanesulfonic acid
C36H56O12S2 (744.3213016000001)